Xcout IntelSign inSubscribe

ZHEJIANG HUAHAI PHARMACEUTICAL CO.,LTD. competitors & alternatives

600521PharmaceuticalsLinhai, China

The 12 closest competitors and alternatives to ZHEJIANG HUAHAI PHARMACEUTICAL CO.,LTD. among pharmaceuticals companies — ranked by similarity to what ZHEJIANG HUAHAI PHARMACEUTICAL CO.,LTD. actually does, not by market-cap band.

$3.9BMarket cap
8,797Employees
12Competitors listed

Subscribe to see ZHEJIANG HUAHAI PHARMACEUTICAL CO.,LTD.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

About ZHEJIANG HUAHAI PHARMACEUTICAL CO.,LTD.

Zhejiang Huahai Pharmaceutical Co., Ltd. is a China-based pharmaceutical enterprise with a global presence. Its diverse portfolio encompasses treatments for central nervous system disorders, cardiovascular conditions, and viral infections, among other finished pharmaceutical products. Beyond finished drugs, the company also produces Active Pharmaceutical Ingredients (APIs) and crucial intermediates. Huahai Pharmaceutical further engages in the manufacturing of packaging components, notably high-density polyethylene (HDPE) bottles and polypropylene (PP) caps. Additionally, it offers contract manufacturing (CMO) and other specialized services, while also playing a role in import and export trade services. Established in 1989, the company maintains its headquarters in Linhai, China.

ZHEJIANG HUAHAI PHARMACEUTICAL CO.,LTD. at a glance

ZHEJIANG HUAHAI PHARMACEUTICAL CO.,LTD. is a pharmaceuticals company headquartered in Linhai, China. It is publicly listed (600521) with a market capitalisation of $3.9B.

Top 12 ZHEJIANG HUAHAI PHARMACEUTICAL CO.,LTD. competitors

Ranked by semantic similarity — how close each company is to ZHEJIANG HUAHAI PHARMACEUTICAL CO.,LTD. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.

HEPALINK09989 · PharmaceuticalsShenzhen, China
64% matchPublic

Similar pharmaceuticals company

Shenzhen Hepalink Pharmaceutical Group Co., Ltd., founded in 1998 and headquartered in Shenzhen, People's Republic of China, operates as an international pharmaceutical company. It is involved in the development, production, and distribution of a wide array of pharmaceutical goods, serving markets in Hong Kong, the United States, Europe, Mainland China, and other global regions. The company's operations are structured across four primary divisions. One key area is Finished Dose Pharmaceutical Products, prominently featuring enoxaparin sodium injection. Another significant segment focuses on Active Pharmaceutical Ingredients (API), supplying essential components like heparin sodium API, enoxaparin sodium API, and other specialized products such as pancreatin API. Hepalink also provides comprehensive services through its Contract Development and Manufacturing Organization (CDMO) arm, which encompasses research and development, manufacturing, quality assurance, and program management. Within its CDMO capabilities, the company is actively involved in creating advanced biopharmaceutical products, including recombinant pharmaceuticals, critical non-viral vectors, gene therapy intermediates, and naturally derived pharmaceutical substances. Beyond its core pharmaceutical activities, Hepalink diversifies its business interests through property management, investment management and advisory services, biopharmaceutical technology development and consulting, and equity and venture capital investments. The company also conducts research, development, and production of biopharmaceuticals, trades medical and biopharmaceutical products, and offers various pharmaceutical-related services. The company officially changed its name from Shenzhen Hepalink Pharmaceutical Co., Ltd. to Shenzhen Hepalink Pharmaceutical Group Co., Ltd. in February 2017.

Market cap$1.8B
Employees2,150
HEPALINK competitors & alternatives →
Solara Active Pharma Sciences LimitedSOLARA · PharmaceuticalsChennai, India
64% matchPublic

Similar pharmaceuticals company

Solara Active Pharma Sciences Limited is an Indian-based pharmaceutical company primarily involved in the comprehensive development, production, and global trade of active pharmaceutical ingredients (APIs). Their activities span the manufacturing, processing, sale, import, and export of these essential drug components. The company's extensive product range includes APIs designed for a wide spectrum of therapeutic applications, such as anesthetics, antibiotics, antivirals, cardiovascular agents, central nervous system treatments, anti-inflammatory drugs, and treatments for metabolic disorders like type-II diabetes, among numerous other specialized categories. Beyond its core product offerings, Solara also delivers specialized contract research and manufacturing services (CRAMS) for APIs. These services encompass custom development and manufacturing, analytical support, impurity synthesis, and comprehensive regulatory assistance. The company maintains a significant international presence, exporting its products and conducting operations across diverse global regions, including the Asia Pacific, Europe, North America, and South America. Headquartered in Chennai, India, Solara Active Pharma Sciences Limited was established in 2017. Initially known as SSL Pharma Sciences Limited, the company adopted its current name in March of the same year.

Market cap$256.9M
Employees2,156
Solara Active Pharma Sciences Limited competitors & alternatives →

Analyze another company

Search any company we track to see its competitive set.

Or describe a company

Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.

See the full profile of ZHEJIANG HUAHAI PHARMACEUTICAL CO.,LTD. and its market

Funding, investors, tech stack, hiring signals, leadership and corporate events — for ZHEJIANG HUAHAI PHARMACEUTICAL CO.,LTD.and every competitor above — in one live dashboard.

Subscribe to Xcout Intel →